MedPath

Pfizer NV/SA

🇧🇪Belgium
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.pfizer.be

Clinical Trials

2

Active:2
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170037
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170043
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170042
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170040
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170044
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170041
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170045
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170038
Approval Date
Jul 1, 2021
NMPA

Dalteparin Sodium Injection

Product Name
法安明
Approval Number
国药准字HJ20170039
Approval Date
Jul 1, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.